21 September 2025 : Clinical Research
tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy
Zofia Twardochleb
ABCDEF 1, Marta Szczepańska ABCDEF 1, Maciej M. Miś CEF 2, Marcin Miś CEF 2, Adam Druszcz DEF 3,4, Małgorzata Paprocka-Borowicz ADEG 5,6*, Joanna Rosińczuk ADEFG 7
DOI: 10.12659/MSM.950237
Med Sci Monit 2025; 31:e950237
Table 6 Treatment effects based on changes in degree of aphasia in groups differing in clinical characteristics.
| Characteristics | Treatment effects Me [Q1–Q3] | ||
|---|---|---|---|
| ΔSODA (pts.) | ΔFAST (pts.) | ΔTT (pts.) | |
| Main disease | |||
| Stroke | 2.5 [1.75–3.5] | 8 [5–11.5] | 8 [0–12.5] |
| TBI | 2 [1–3] | 6 [3–10] | 3 [3–10] |
| Stroke+TBI | 2.5 [2–4] | 10 [4–17] | 0 [0–17] |
| p-value | p=0.082 | p=0.251 | p=0.694 |
| Number of incidents | |||
| One | 2.5 [1.5–3.5] | 8 [4–11] | 5 [0–13] |
| Two | 2 [1.5–2] | 6 [5–7] | 9 [4–10] |
| p-value | p=0.264 | p=0.491 | p=0.508 |
| TBI – traumatic brain injury; SODA – Aphasia Evaluation Scale; FAST – Frenchay Aphasia Screening Test; TT – Token Test. | |||